145 related articles for article (PubMed ID: 27274271)
1. Single-nucleotide polymorphism in microRNA-binding site of SULF1 target gene as a protective factor against the susceptibility to breast cancer: a case-control study.
Zhou Q; Jiang Y; Yin W; Wang Y; Lu J
Onco Targets Ther; 2016; 9():2749-57. PubMed ID: 27274271
[TBL] [Abstract][Full Text] [Related]
2. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.
Bagheri F; Mesrian Tanha H; Mojtabavi Naeini M; Ghaedi K; Azadeh M
Mol Med Rep; 2016 May; 13(5):4494-8. PubMed ID: 27035115
[TBL] [Abstract][Full Text] [Related]
3. miR-485-5p binding site SNP rs8752 in HPGD gene is associated with breast cancer risk.
He N; Zheng H; Li P; Zhao Y; Zhang W; Song F; Chen K
PLoS One; 2014; 9(7):e102093. PubMed ID: 25003827
[TBL] [Abstract][Full Text] [Related]
4. Rs3802278 in 3'-UTR of
Zeng F; Liu Y; Ouyang Q; Sun Z; Zhang K; Li X; Liu Y
J Chemother; 2021 Dec; 33(8):564-569. PubMed ID: 34029511
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome.
Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L
Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300
[TBL] [Abstract][Full Text] [Related]
6. Impact of Genetic Variation in MicroRNA-binding Site on Susceptibility to Colorectal Cancer.
Kang BW; Jeon HS; Chae YS; Lee SJ; Park JS; Choi GS; Kim JG
Anticancer Res; 2016 Jul; 36(7):3353-61. PubMed ID: 27354594
[TBL] [Abstract][Full Text] [Related]
7. Prostate stem cell antigen single nucleotide polymorphisms influence risk of estrogen receptor negative breast cancer in Korean females.
Kim SY; Yoo JY; Shin A; Kim Y; Lee ES; Lee YS
Asian Pac J Cancer Prev; 2012; 13(1):41-8. PubMed ID: 22502712
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations in the flanking regions of miR-101-2 are associated with increased risk of breast cancer.
Chen J; Qin Z; Jiang Y; Wang Y; He Y; Dai J; Jin G; Ma H; Hu Z; Yin Y; Shen H
PLoS One; 2014; 9(1):e86319. PubMed ID: 24475105
[TBL] [Abstract][Full Text] [Related]
9. Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status.
Cen YL; Qi ML; Li HG; Su Y; Chen LJ; Lin Y; Chen WQ; Xie XM; Tang LY; Ren ZF
Mol Carcinog; 2013 Nov; 52 Suppl 1():E52-9. PubMed ID: 23143756
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphism in the 3' untranslated region of LPP is a risk factor for lung cancer: a case-control study.
Yan S; Sun R; Wu S; Jin T; Zhang S; Niu F; Li J; Chen M
BMC Cancer; 2019 Jan; 19(1):35. PubMed ID: 30621612
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in microRNA let-7 binding sites of the
Du Y; Zhou L; Lin Y; Yin K; Yin W; Lu J
Ann Transl Med; 2019 Apr; 7(7):138. PubMed ID: 31157259
[TBL] [Abstract][Full Text] [Related]
12. An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset.
Song F; Zheng H; Liu B; Wei S; Dai H; Zhang L; Calin GA; Hao X; Wei Q; Zhang W; Chen K
Clin Cancer Res; 2009 Oct; 15(19):6292-300. PubMed ID: 19789321
[TBL] [Abstract][Full Text] [Related]
13. G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer.
Li Y; Nie Y; Cao J; Tu S; Lin Y; Du Y; Li Y
Mol Carcinog; 2014 Mar; 53(3):219-29. PubMed ID: 23065816
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.
Xiong F; Wu C; Chang J; Yu D; Xu B; Yuan P; Zhai K; Xu J; Tan W; Lin D
Cancer Res; 2011 Aug; 71(15):5175-81. PubMed ID: 21676885
[TBL] [Abstract][Full Text] [Related]
15. [Associations between TOX3 rs3803662 polymorphisms and immunological markers of breast cancer].
Chen Q; He Y; Liu C; Liu H; Sun X; Shao Y; Huang T; Xu B
Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(34):2783-6. PubMed ID: 26711978
[TBL] [Abstract][Full Text] [Related]
16. rs15869 at miRNA binding site in BRCA2 is associated with breast cancer susceptibility.
Cao J; Luo C; Yan R; Peng R; Wang K; Wang P; Ye H; Song C
Med Oncol; 2016 Dec; 33(12):135. PubMed ID: 27807724
[TBL] [Abstract][Full Text] [Related]
17. Functional SNP in microRNA-491-5p binding site of MMP9 3'-UTR affects cancer susceptibility.
Pirooz HJ; Jafari N; Rastegari M; Fathi-Roudsari M; Tasharrofi N; Shokri G; Tamadon M; Sazegar H; Kouhkan F
J Cell Biochem; 2018 Jul; 119(7):5126-5134. PubMed ID: 29091292
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA related polymorphisms and breast cancer risk.
Khan S; Greco D; Michailidou K; Milne RL; Muranen TA; Heikkinen T; Aaltonen K; Dennis J; Bolla MK; Liu J; Hall P; Irwanto A; Humphreys K; Li J; Czene K; Chang-Claude J; Hein R; Rudolph A; Seibold P; Flesch-Janys D; Fletcher O; Peto J; dos Santos Silva I; Johnson N; Gibson L; Aitken Z; Hopper JL; Tsimiklis H; Bui M; Makalic E; Schmidt DF; Southey MC; Apicella C; Stone J; Waisfisz Q; Meijers-Heijboer H; Adank MA; van der Luijt RB; Meindl A; Schmutzler RK; Müller-Myhsok B; Lichtner P; Turnbull C; Rahman N; Chanock SJ; Hunter DJ; Cox A; Cross SS; Reed MW; Schmidt MK; Broeks A; Van't Veer LJ; Hogervorst FB; Fasching PA; Schrauder MG; Ekici AB; Beckmann MW; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Benitez J; Zamora PM; Perez JI; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Pharoah PD; Dunning AM; Shah M; Luben R; Brown J; Couch FJ; Wang X; Vachon C; Olson JE; Lambrechts D; Moisse M; Paridaens R; Christiaens MR; Guénel P; Truong T; Laurent-Puig P; Mulot C; Marme F; Burwinkel B; Schneeweiss A; Sohn C; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Andrulis IL; Knight JA; Tchatchou S; Mulligan AM; Dörk T; Bogdanova NV; Antonenkova NN; Anton-Culver H; Darabi H; Eriksson M; Garcia-Closas M; Figueroa J; Lissowska J; Brinton L; Devilee P; Tollenaar RA; Seynaeve C; van Asperen CJ; Kristensen VN; ; ; Slager S; Toland AE; Ambrosone CB; Yannoukakos D; Lindblom A; Margolin S; Radice P; Peterlongo P; Barile M; Mariani P; Hooning MJ; Martens JW; Collée JM; Jager A; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Giles GG; McLean C; Brauch H; Brüning T; Ko YD; ; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Swerdlow A; Ashworth A; Orr N; Jones M; Simard J; Goldberg MS; Labrèche F; Dumont M; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Kataja V; Kosma VM; Hartikainen JM; Mannermaa A; Hamann U; Chenevix-Trench G; Blomqvist C; Aittomäki K; Easton DF; Nevanlinna H
PLoS One; 2014; 9(11):e109973. PubMed ID: 25390939
[TBL] [Abstract][Full Text] [Related]
19. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
Sung H; Lee KM; Choi JY; Han S; Lee JY; Li L; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
Breast Cancer Res Treat; 2011 Dec; 130(3):939-51. PubMed ID: 21766210
[TBL] [Abstract][Full Text] [Related]
20. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
